PAS
ARKG icon

Park Avenue Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Park Avenue Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,050
Closed -$232K – 1465
2024
Q3 		$232K Sell
9,050
-1,615
-15% -$41.1K ﹤0.01% 1286
2024
Q2 		$250K Sell
10,665
-1,002
-9% -$25.3K ﹤0.01% 1240
2024
Q1 		$336K Buy
11,667
+1,435
+14% +$43.2K ﹤0.01% 1135
2023
Q4 		$336K Buy
10,232
+203
+2% +$5.52K ﹤0.01% 1071
2023
Q3 		$279K Buy
+10,029
New +$328K ﹤0.01% 1078
2023
Q2 		– Sell
-11,611
Closed -$349K – 723
2023
Q1 		$349K Sell
11,611
-2,110
-15% -$65.4K 0.01% 649
2022
Q4 		$387K Sell
13,721
-2,101
-13% -$66.7K 0.01% 874
2022
Q3 		$520K Buy
15,822
+2,139
+16% +$78.5K 0.01% 696
2022
Q2 		$431K Sell
13,683
-940
-6% -$32.9K 0.01% 756
2022
Q1 		$672K Buy
14,623
+373
+3% +$17.8K 0.01% 618
2021
Q4 		$873K Buy
14,250
+7,271
+104% +$503K 0.02% 523
2021
Q3 		$521K Buy
6,979
+4,222
+153% +$354K 0.01% 617
2021
Q2 		$255K Buy
+2,757
New +$234K 0.01% 906

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Park Avenue Securities's ARKG Position: Q4 2024 in Review

Park Avenue Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 9,050 shares — an estimated $232K sold.

Park Avenue Securities first reported a position in ARKG in Q2 2021 and held it in 13 quarters. The position peaked at $873K in Q4 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Park Avenue Securities reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Park Avenue Securities sold 9,050 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $232K.
  • Park Avenue Securities first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 13 quarters.
  • Park Avenue Securities's ARK Genomic Revolution ETF position peaked at $873K in Q4 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Park Avenue Securities's 13F filing for Q4 2024, filed 14 Jan 2025.